Aminoglycoside antibiotics and neuromuscular blockade.
D000617:Aminoglycosides / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D006801:Humans; D066298:In Vitro Techniques; D009466:Neuromuscular Blocking Agents; D051381:Rats
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D009466:Neuromuscular Blocking Agents